Liver Care for Frontline Clinicians (Denver)
Date : Saturday, November 7, 8:00 am - 4:30 pm (EST) Location : Hyatt Regency Denver Continuing Education Credits : Maximum of 7.0 AMA PRA Category 1 Credits™
Please note this event takes place in Denver and is scheduled in Mountain Time.
Organized by: Past President, W. Ray Kim and Elizabeth Aby
Co-organizers: Mia Lozada, Hazel Domingo, Jimyeong Son, Christine Esquivel, Shraddha Batra, and Ashley Kell
With approximately 41.4% or 122 million American adults predicted to have MASLD by 2050, clinicians play a critical role in early detection and prevention, and this is why AASLD created Liver Care for Frontline Clinicians: From Assessment to Intervention. The program is designed to empower practitioners in primary care, internal medicine, emergency medicine, gastroenterology, and advanced practice roles with the skills to prevent, detect, and manage liver disease across the continuum of care, without adding complexity to an already full patient visit. This practical, case-based program focuses on integrating liver health into friendly routine workflows that fit naturally into everyday practice.
View the Program
Saturday, Nov 7
- 8 a.m. Welcome & Intro
- 8:05 – 9:45 a.m. Liver Health Essentials: What Every Clinician Must Know
- 8:05 a.m.: Why Preventative Hepatology?
- 8:25 a.m.: Natural History of Chronic Liver Disease
- 8:45 a.m.: Laboratory Evaluation of the Liver
- 9:05 a.m.: Liver Imaging and Elastography
- 9:25 a.m.: Audience Q&A
- 10:05 – 11:45 a.m.: The New Landscape of Steatotic Liver Disease
- 10:05 a.m.: Navigating the Spectrum: Screening and Diagnosis of MASLD and ALD in Primary Care
- 10:25 a.m.: Food for the liver: High-Yield Counseling in Nutrition For Liver Health
- 10:45 a.m.: Holistic Care of Liver Patients: Non-Dietary Lifestyle Changes and Co-Morbidity Management
- 11:05 a.m.: MASLD: Decisions for Treatment, Referral and Monitoring
- 11:25 a.m.: Audience Q&A
- 11:45 a.m. – 12:40 p.m.: Lunch
- 12:40 – 2:20 p.m.: Secondary Prevention: Eliminating Liver Disease Impact
- 12:40 p.m.: Viral Hepatitis: Eliminating Hepatitis B & C in Primary Care
- 1 p.m.: Autoimmune and Cholestatic Liver Disease: Recognition and Management in Primary Care
- 1:20 p.m.: Alcohol Use Disorder in Liver Disease: Treatment Strategies and Transplant Referral Timing
- 1:40 p.m.: Alcohol-Related Liver Disease: Best Practices in Communication, Risk Stratification, and Non-Invasive Assessment
- 2 p.m.: Audience Q&A
- 2:40 – 4:20 p.m.: Preventive Hepatology: Actionable Tools for Frontline Clinicians
- 2:40 p.m.: A Practical Approach to Medication Management Across the Spectrum of Liver Health
- 3 p.m.: Cirrhosis in Primary Care: How to Keep the Patient Healthy and When to Refer for Transplantation
- 3:20 p.m.: What My Clinic Looks Like: Infrastructure, The Team and the System of Support
- 3:40 p.m.: Creating a Liver Toolbox: Clinical Pearls for Primary Care
- 4 p.m.: Case Review/Q&A
- 4:20 – 4:25 p.m.: Closing
Why This Matters Now
The burden of liver disease continues to rise, and with the global adoption of new liver disease definitions — including Metabolic dysfunction–Associated Steatotic Liver Disease (MASLD), Alcohol-Associated Liver Disease (ALD), and Metabolic and Alcohol-Related Liver Disease (MetALD) — the clinical landscape is changing. AASLD is committed to empowering and partnering with healthcare professionals to help change the epidemiological trajectory.
Your role is crucial. Patients at risk for liver disease often have co-morbidities such as type 2 diabetes, obesity, cardiovascular disease, alcohol use disorder, hypertension, and kidney disease. By addressing the underlying liver condition, you can directly improve the patient’s overall health and positively impact these associated conditions. With MASLD and ALD highly prevalent in primary care, early recognition and timely intervention through earlier diagnosis, intervention, and integrated preventative care can profoundly improve long-term patient outcomes.
What You’ll Gain
- Apply principles of primary and secondary prevention to screen for, diagnose, and manage patients with liver disease in primary care settings.
- Interpret and utilize noninvasive diagnostic tools, including laboratory tests and elastography, to assess liver disease and guide treatment and referral decisions.
- Implement evidence-based management and surveillance protocols for chronic liver diseases.
- Incorporate behavioral and pharmacologic strategies for steatotic liver disease into routine care to improve liver health.
- Integrate practical workflow solutions and multidisciplinary collaboration into clinical practice to support sustainable, patient-centered liver health care delivery.
By attending this one-day session, you are at the forefront of preventative hepatology. Join this timely program and be part of the prevention and improvement of liver health. Change the trajectory of liver disease and register today!
CE Accreditation
Accreditation Statement
The American Association for the Study of Liver Diseases is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association for the Study of Liver Diseases designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registration Pricing
Attend the one-day program with lunch and afternoon snacks and coffee provided.
| Registration Rate | |
|---|---|
| Physician | $250 |
| Resident/Trainee (Post-Doc) | $100 |
| Associates (RN, NP, PharmD) | $100 |
| Student | $50 |
| Industry | $450 |
Cancellation policy: Cancellations must be made in writing to meetings@aasld.org before April 17, 2026. A 10% cancellation fee will be applied to the refund. Any cancellations starting April 17, 2026, will not be refunded.